Table 3.
Prospective studies investigating adoptive cell therapy in the context of allogeneic transplantation for acute myelogenous leukemia in adults
NK indicates natural killer; WT1, Wilms Tumor-1; AML, acute myelogenous leukemia; MDS, myelodysplastic syndrome; HSCT, hematopoietic stem cell transplant; NK, natural killer; IL-2, interleukin-2; TBI, total body irradiation; SQ, subcutaneously; GVHD, graft-versus-host disease; DLI, donor lymphocyte infusion; PBSC, peripheral blood stem cells; SCT, stem cell transplant; TCR, T cell receptor; and ATG, anti-thymocyte globulin.
